Cargando…
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) cause a considerable burden of morbidity and mortality in low-income and middle-income countries (LMICs). Access to safe, effective, quality-assured, and affordable essential medicines is variable. We aimed to review the existing li...
Autores principales: | Stolbrink, Marie, Thomson, Helen, Hadfield, Ruth M, Ozoh, Obianuju B, Nantanda, Rebecca, Jayasooriya, Shamanthi, Allwood, Brian, Halpin, David M G, Salvi, Sundeep, de Oca, Maria Montes, Mortimer, Kevin, Rylance, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638033/ https://www.ncbi.nlm.nih.gov/pubmed/36113528 http://dx.doi.org/10.1016/S2214-109X(22)00330-8 |
Ejemplares similares
-
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
por: Stolbrink, M., et al.
Publicado: (2022) -
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?
por: Mortimer, K., et al.
Publicado: (2022) -
Meeting Unmet Needs in Chronic Obstructive Pulmonary Disease Diagnosis and Treatment in Low- and Middle-Income Countries
por: Ozoh, Obianuju B., et al.
Publicado: (2023) -
Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019) -
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)